Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy male volunteers evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of GSK2849466 and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cachexia

Drugs mentioned

• GSK2849466

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cachexia | Phase 1 | Status: COMPLETED